SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-100999
Filing Date
2022-04-11
Accepted
2022-04-11 07:55:55
Documents
13
Period of Report
2022-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d336385d8k.htm   iXBRL 8-K 24827
2 EX-99.1 d336385dex991.htm EX-99.1 10401
  Complete submission text file 0001193125-22-100999.txt   162126

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rxrx-20220411.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxrx-20220411_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxrx-20220411_pre.xml EX-101.PRE 11263
7 EXTRACTED XBRL INSTANCE DOCUMENT d336385d8k_htm.xml XML 3377
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 22818497
SIC: 2836 Biological Products, (No Diagnostic Substances)